JCP Investment Management LLC Purchases 115,062 Shares of The Joint Corp. $JYNT

JCP Investment Management LLC lifted its position in shares of The Joint Corp. (NASDAQ:JYNTFree Report) by 24.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 593,906 shares of the company’s stock after purchasing an additional 115,062 shares during the period. Joint accounts for approximately 3.7% of JCP Investment Management LLC’s investment portfolio, making the stock its 9th biggest holding. JCP Investment Management LLC owned approximately 4.00% of Joint worth $5,666,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. BNP Paribas Financial Markets boosted its stake in Joint by 104.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,935 shares of the company’s stock valued at $28,000 after purchasing an additional 1,501 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Joint by 25.9% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,244 shares of the company’s stock worth $95,000 after buying an additional 1,698 shares during the period. JPMorgan Chase & Co. increased its position in Joint by 32.3% during the 2nd quarter. JPMorgan Chase & Co. now owns 7,412 shares of the company’s stock worth $86,000 after buying an additional 1,810 shares during the period. Verus Capital Partners LLC lifted its holdings in shares of Joint by 1.7% during the third quarter. Verus Capital Partners LLC now owns 113,426 shares of the company’s stock worth $1,082,000 after buying an additional 1,947 shares in the last quarter. Finally, American Century Companies Inc. lifted its holdings in shares of Joint by 13.9% during the second quarter. American Century Companies Inc. now owns 27,572 shares of the company’s stock worth $318,000 after buying an additional 3,366 shares in the last quarter. 76.88% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Joint in a research note on Thursday, January 22nd. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Joint has an average rating of “Hold” and a consensus target price of $17.00.

View Our Latest Stock Report on JYNT

Joint Trading Up 2.3%

Shares of JYNT stock opened at $8.40 on Monday. The stock has a market cap of $124.91 million, a P/E ratio of 44.21 and a beta of 1.33. The Joint Corp. has a 1 year low of $7.50 and a 1 year high of $13.47. The stock has a 50 day simple moving average of $9.27 and a 200 day simple moving average of $9.07.

Joint (NASDAQ:JYNTGet Free Report) last posted its quarterly earnings data on Thursday, March 12th. The company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.02. The firm had revenue of $15.17 million for the quarter, compared to analyst estimates of $14.12 million. Joint had a negative return on equity of 1.28% and a net margin of 4.99%. Analysts forecast that The Joint Corp. will post 0.11 EPS for the current year.

Insider Activity

In related news, major shareholder Charles E. Jobson purchased 15,397 shares of the firm’s stock in a transaction that occurred on Thursday, February 12th. The shares were bought at an average price of $8.50 per share, for a total transaction of $130,874.50. Following the completion of the transaction, the insider owned 1,645,294 shares of the company’s stock, valued at approximately $13,984,999. This trade represents a 0.94% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Over the last quarter, insiders acquired 37,849 shares of company stock worth $348,981. Corporate insiders own 27.90% of the company’s stock.

Joint Profile

(Free Report)

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.

Featured Articles

Want to see what other hedge funds are holding JYNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Joint Corp. (NASDAQ:JYNTFree Report).

Institutional Ownership by Quarter for Joint (NASDAQ:JYNT)

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.